Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
American Liberty Petroleum Corp. Cancels Majority of Its Stock
HOUSTON, Oct 02, 2014 (GLOBE NEWSWIRE via COMTEX) -- American Liberty Petroleum Corp. (OTCBB:OREO) announces today that it will cancel over sixty three percent (63%) of the company's outstanding Common Stock shares. Three major shareholders have signed an agreement to exchange stock certificates, owned by them and already submitted to the company's CFO, for one million (1,000,000) Common Stock shares each - for a total of over sixty eight million (68,469,993) Common Stock shares being cancelled and three million (3,000,000) being issued.
"These shareholders, including the Chief Executive Officer prior to Mr. Rhodes, believe that our current management team and its plan focusing on enhancing shareholder value will bring major benefits to our shareholders," said Steven M. Plumb, American Liberty Petroleum Corp.'s Chief Financial Officer. "With 107,389,051 Common Stock shares outstanding as of the filing of our last 10Q, we are cancelling over sixty three percent (63%) of the outstanding Common Stock shares."
The previously disclosed letter of intent for acquisition of Avant Diagnostics Inc. contemplates a closing date by October 1, 2014, based upon successful conclusion of due diligence, which is ongoing by both parties. The parties have signed an amended letter of intent providing for a later closing, October 31, after Avant Diagnostics Inc. submits a PCAOB audit to the company as part of the due diligence.
Shareholders should also note that Mr. Hunter M.A. Carr no longer has any position nor ownership in American Liberty Petroleum Corp. The Board of Directors accepted Mr. Carr's resignation as Chairman on August 30, 2014.
OREO, cash/asset/revenue: $0. Loss: $3.1 M, LOL!
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10211885
The market cap for OREO is ------
The stock price X at least 107 million shares. That market cap will be 3.5% of the Reverse Merger company.
So at 4 cents for OREO, you are valuing the reverse merger company at $122 million.
Avant values itself at less than $10 million and IMGO, it's less than $5 million.
Even if you use $8 million, OREO would need to fall 94% to get down to that valuation.
Very typical in the world of micro pennies and tiny pennies.
It's a typical case of (IMHO) where 95% of the trading is made up from (a)"greater fool" traders who don't care if a stock is trading at levels that could drop 95% in minutes, (b) people that are so clueless they don't understand anything but see MB pumps, large gains, etc. and (c) people whoever they may be that are actually involved in market manipulation to stimulate the impact of (a) or (b) ---- with no idea who might be behind any manipulation activities or why.
True. It's interesting and exciting to see where this goes with respect to ArrayIt and ovadx
OREO used to be a financial services company. Before that, they were in the clothing industry. Then medical marijuana. They were into dot coms way back. Now petroleum. OREO never made an honest dime. Pump n dump stock.
OREO can drop 95% to reflect a reasonable value for Avant DX/b]
Yeah, like the pumping operation by Arrayit DX and John Howell in December 2009:
"OvaDx(TM) Pre-Symptomatic Ovarian Cancer Blood Test, which is currently advancing through late-stage development"
"we are pleased to confirm that Arrayit Diagnostics will file for Pre-Market Approval of our early stage ovarian cancer test as an 'In Vitro Diagnostic Multivariate Index Assay' shortly after the end of this year."
[That would have been early 2010]
"official commercial launch to the medical diagnostics industry as early as the third quarter of 2010."
You mean if they raise the money to do the necessary testing to prove it works and to seek FDA approval and to raise the money to create a sales, distribution and processing operation? Then the years to get peer review and piecemeal insurance coverage?
Time to see OvaDx brought to market. I'm glad to see this moving forward in favor of shareholders and the test. Good luck to Oreo.
Hmmmmmm. I will certainly look into this for sure. Thanks for the links.
More research.
The Harris County Court online records include a a lawsuit filed by Digerati on 2/04-2013 against several parties, including Robert C. Rhodes. One can go to the site and read all the filings in this case. there are many and over many months.
The initial Petition filed by Digerati included Exhibits 1 and 3 which were "Declarations" by Digerati's CEO Art Smith and by former CEO of Digerati and of Arrayit DX, John Howell.
Howell's Declaration is below and Art Smith's will be in the next post.
Additional research on Avant DX
Avant's pulled 2012 S-1 (Arrayit DX at the time) included the following on certain shares sold in 2012:
http://www.sec.gov/Archives/edgar/data/1558297/000114420412061332/v327732_s1.htm
"Item 15. Recent Sales of Unregistered Securities "
On January 4, 2012, we issued for $10,000 cash, 50,000 shares of common stock to Bettina Mackenbach in reliance upon the exemption from registration in Rule 506 of Regulation D under the Securities Act.
On January 4, 2012, we issued for $10,000 cash, 50,000 shares of common stock to Jukka Tolonen in reliance upon the exemption from registration in Rule 506 of Regulation D under the Securities Act.
These two are husband and wife.
Here is some info on Jukka (who lives in the Houston, TX area - Sugarland).
http://www.justice.gov/usao/dc/news/2009/nov/09-284.pdf
http://www.justice.gov/usao/dc/news/2010/apr/10-081.pdf
More research on Avant DX (previously Arrayit Diagnostics).
http://www.sec.gov/Archives/edgar/data/1084507/000079894712000040/0000798947-12-000040-index.htm
December 17, 2012 – Arrayit Corporation (OTCBB: ARYC) announces that as of December 12, 2012, Mr. John Howell, President and CEO of its majority owned subsidiary, Arrayit Diagnostics, Inc., has resigned his position. Effective December 15, 2012, Mr. Steven Scott was appointed to replace John Howell in all his capacities. Further, Arrayit Diagnostics, Inc has elected not to pursue the opportunity with Yarra.
Steven Scott is Steven Eugene Scott of Arizona and formerly of California and Massachusetts.
Steven Eugene Scott's Chapter 7 filing in Arizona BK Court on 11/24/2010 - Case 2:10-bk-37880-SSC
There was an older Chapter 7 filing in CA as well.
Also when he became CEO of Avant, the Avant web page presented his bio, claiming he had an MBA. After this was challenged on the Yahoo MB, the bio was changed to something along the lines of he had taken some graduate courses.
Interesting document to read
I found this recently filed document in the Digerati case an interesting read ------ Docket item 994
http://dm.epiq11.com/DIG/Docket#Debtors=5178&RelatedDocketId=&ds=true&maxPerPage=25&page=1
Besides the entirety, page one and the footnote 1 are interesting comments.
Docket item 971 is another I found worthy of reading. It responded to #970.
All can be read for free at the link above.
More from Harris County Court records.
If you search the Harris County Court records where Michael Carr is a party, you will find a 1985 case as follows:
Details in the pleading immediately above (Image No. 23796172 in the specific case images - titled X - Casefile Documents)include the following "VII" and "VIII"
You will note that from the various posts here, the article said convicted and sentenced to 3 years and served 6 months. The images above claim this Michael A Carr began serving time on June 17, 1985 and the prison search info shows a Michael A Carr released on 1/13/1986 (6 months after 6/1985)
And check out Bizapedia that ties the company Micro legal services to Hunter / Michael Carr
http://www.bizapedia.com/addresses/PO-BOX-421566-HOUSTON-TX-77242.html
There are 17 companies that have an address matching Po Box 421566 Houston, TX 77242-1566.
The companies are National Law Library Inc, Emis Software Manufacturers Inc, Onpoint Solutions Inc, Rainmaker Ventures Ii Ltd, Amazing Ministry Foundation, Victorias Own Co, Executive Database Controls Inc, Recap Marketing Consulting LLP, Itis Holdings Inc, Itis Inc, Pharmhouse Inc, Rmac LLC, Michael Carr Company, Micro Legal Services Inc, Mlsi Inc, Rx Pain LLC, and 2rv LLC.
Also I think but haven't verified that the Vicki Campbell in the litigation documents is Hunter Carr's wife Vicki Carr
Really? Try his real name, Mr. Hunter M.A. Carr!! His name is Hunter.... Prisons don't book folks to prison without their full names disclosed. My father is a warden of a prison so I know this to be a FACT!! GLTU
http://investing.businessweek.com/research/stocks/private/person.asp?personId=409888&privcapId=409886&previousCapId=84007352&previousTitle=VIRTUS%20OIL%20AND%20GAS%20CORP
This link can be used to research people.
http://www.bop.gov/inmateloc/
Enter "Michael A Carr" into the appropriate fields. This appears to be the person who's Chairman of OREO. One should verify all this for themselves if they view it as relevant to any matters.
http://www.bop.gov/inmateloc/
From OREO's last 10-K
http://www.sec.gov/Archives/edgar/data/1451929/000158069514000056/oreo10k103113.htm
"In January 2014, Mr. Hunter M.A. Carr, Mr. Robert C. Rhodes and Mr. Steven M. Plumb were elected to serve on the Board of Directors of the Company (the Board) and Mr. Vollmers resigned from his positions on the Board and as President, Secretary and Treasurer. Mr. Carr was elected to serve as Chairman of the Board, Mr. Rhodes was elected to serve as President and Chief Executive Officer and Mr. Plumb was elected to serve as Chief Financial Officer, Vice President of Finance, Secretary and Treasurer."
The following is an Exhibit to a 2012 8-K from Digerati showing who would own shares in Digerati after the November 2012 reverse merger. BTW, information in the public domain indicates Cloud Capital is controlled by Hunter Carr.
http://www.sec.gov/Archives/edgar/data/1014052/000114420412065898/v329588_ex2-1.htm
OvaDX is from 2009 and ARYC said it would be FDA approved and on the market by Q3 2010. ARYC has pumped Ova DX for 5 years. ARYC / Avant DX tried an S-1 spin off in November 2012 and that flopped (and the SEC had issues). Avant's CEO even resigned very soon after the S-1 filing to go become CEO of another "reverse merger" company involving Carr and Rhodes.
From SEC filings none of ARYC, Avant and OREO appear to have cash and they haven't been able to raise the money to develop, test and file for even the preliminary FDA step for 5 years.
Check out the background of Hunter M.A. Carr. He's Chairman of OREO, major shareholder in Avant DX and owner of RECAP MARKETING.
Robert Rhodes (CEO of OREO) and Hunter Carr jointly own American Equity Fund.
See these 8-K's from Digerati. Rhodes, Carr and RECAP were the "consultants" on the 2012 Digerati reverse merger. Digerati filed Chapter 11 in June 2013. John Howell is a long time associate of Hunter Carr, was CEO of Avant DX from 2009 until December 2012 when he became CEO of Digerati (resigned 30 days later).
http://www.sec.gov/Archives/edgar/data/1014052/000114420413004811/v333396_8k.htm
http://www.sec.gov/Archives/edgar/data/1014052/000121390013001282/f8k030413_digerati.htm
As to certain names in the 8-K's, William McIlwain has been described in one court filing as Hunter Carr's neighbor and golf buddy and Kelly Kirker is related to Hunter Carr by marriage.
Hunter Carr is part of an the subject matter of an article on the Intenet called "preditor or prey". His name use to be Michael A Carr until he had it legally changed in 1990.
http://investorvoice.ca/PI/234.htm
This article notes:
"The group is also attacking Carr's credibility. An investigator it hired found that, in the early 1980s, Carr was arrested, indicted and convicted in federal court on one charge of conspiracy to defraud. For that, Carr was sentenced to three years in prison. (He served six months.)"
On can go to the Harris County Court online search pages and see legal proceedings from all the way back into the 1980's that include entities like Michael Alan Carr, Hunter Carr, RECAP Marketing, Robert Rhodes, Rhodes Holdings, etc. You can even see an existing lawsuit here between RECAP Marketing and Arrayit.
Click on the "Party Inquiry: tab and search as you desire. You can register and have free access to all filings in any case.
http://www.hcdistrictclerk.com/eDocs/Public/Search.aspx
One can view all the legal filings in the Digerati Chapter 11 case for free here.
http://dm.epiq11.com/DIG/Docket#Debtors=5178&RelatedDocketId=&ds=true&maxPerPage=25&page=1
Just a little DD. I'm sure most may already know most of this. Just thought I would share a little while we all wait to see what's going on.
Mr. Robert C Rhodes
http://www.linkedin.com/in/robertrhodes
No oil. Check ArrayIt.com and the OvaDx test.
something new vended in to this one? no more oil? MMJ?
Time to buy some more and make some dough on the OvaDx potential test marketing. Love it!
OREO valuing RM at $122 million versus the actual RM company valuing itself at under $10 million. And IHMO, it's not worth anything close to the $10 million. Maybe $3 0r $4 million
And Avant DX said in 2009 and early 2010 that OvaDX would be on the market in Q3 2010, with FDA approval. They are over 4 years behind that timeline
Time to make money on bringing Ovadx to market
And Avant DX said in 2009 and early 2010 that OvaDX would be on the market in Q3 2010, with FDA approval. They are over 4 years behind that timeline
Nothing but losses, no capital, no proven product and needs significant funds and time to try and get a product validated, submitted to the FDA, approved by the FDA, accepted in the industry / insurance market, distribution, marketing, etc.
And todays OREO price is placing a value of over $60 million on the reverse merger entity, an entity that doesn't even value itself over $10 million....and IMHO, Avant values their company multiples of what it's worth today.
Maybe but I still will make money.
One worthless company for another company worth very little and in turmoil for the last 5 years (Avant Diagnostics)
I think this applies to the oil and gas business that never happened. They are basically acquiring the Avant diagnostics to bring that entity public to market the OvaDx test and bring it public. Good times
I think the original public company was named Orion or Oreon something
All I need to read:
A company named after a cookie sounds like a P&D.
Just dropped 62.5%
Now just dropped over 75%
OREO valuing RM at $122 million versus the actual RM company valuing itself at under $10 million. And IHMO, it's not worth close to the $10 million.
Downside risk in OREO right now is as high as a 95% drop from 4 cents
General the opportunity is here for u as well. P&d or not. It's all about potentiality and timing
And the public company that owns over 50% of the reverse merger entity and has their own business and another venture they own 25% of has a total value of under $10 million, and it (ARYC) is probably overpriced at 15 cents a share....IMHO
And people here are paying over $90 million....lol
Greatest FOOL Theory at play
Last trade values the reverse merge entity at $92 million. Yet the actual reverse merger entity is valuing itself at less than $10 million and that is probably 50% more than is rational.
Nice paint job in the last few seconds.
I wonder who might have done that?
Correction of "not" to "now"
People are now buying shares for a valuation of the post merger company of over $53 million.
That company actually has recently valued itself at under $10 million and ARYC owns over 50% of the reverse merger company and their total market cap is under $10 million.
People are not buying shares for a valuation of the post merger company of over $53 million.
That company actually has recently valued itself at under $10 million and ARYC owns over 50% of the reverse merger company and their total market cap is under $10 million.
If you have a though about buying OREO, buy ARYC instead and get in for 25% of what you are paying here. But IMHO, ARYC is overvalued at 15 cents. Roll the dice and hope somebody pays more than you and that pump / dump activity is coming.
Buyers here are insane. You are valuing the post merger entity at multiples of what they players value it at.
People paying $0.013 are valuing this shell at $1.4 million. This shell will end up with a 3.5% stake in the reverse merger company.
That values the post reverse merger company at an INSANE $40.1 million.
Arrayit (ARYC) owns over 50% of the company doing the reverse merger (with the new 20 million shares of Avant they get). ARYC has their own business and a 25% interest in another company they spun off their technology into.
ARYC total market cap is under $10 million.
So people here are valuing the reverse merger company at $40,000,000. ARYC's valuation considers their over 50% share at less than $5 million (or a total for the reverse merger OREO under $10 million).
Avant, the reverse merger entity has recently valued their company at less than $10 million.
Followers
|
30
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1673
|
Created
|
11/13/11
|
Type
|
Free
|
Moderators |
American Liberty Petroleum Corp.
4900 California Ave.
Tower B-210
Bakersfield, CA
93309
T: 661-377-2911
F: 661-377-1848
Email: info@americanlibertypetro.com
Web: www.americanlibertypetro.com
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |